Managing Partner at emergentec biodevelopment GmbH. emergentec, founded in 2002 in Vienna (Austria), develops concepts and software technologies for data rich R&D in Life Sciences and technology analogs.
During the last decade Arno has been designing molecular pathology and drug mechanism of action models for integrated decision support in biomarker, drug target and drug selection. He has contributed to the development of the software technology “e.valuation”, in active use for drug positioning/repositioning.
Arno has been involved in several large, integrated European Commission funded research initiatives, and his work resulted in more than 40 peer-reviewed papers in the area of computational biology, bioinformatics and biopharmaceutical research.
Arno Lukas holds a PhD in Biochemistry from the University of Vienna.